Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled time : 15:30 save search
AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 5.03%
H: 0.0%
C: -3.82%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 53.48%
H: 1.02%
C: 0.26%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.54%
H: 0.06%
C: -0.78%
vaccine astrazeneca positive acquire rsv potential
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19 Vaccine
Published: 2023-10-05 (Crawled : 15:30) - biospace.com/
PRGO | $29.94 -0.33% -0.6% 970K
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda vaccine approval
Pfizer Notches Breakthrough Status in Race to an RSV Vaccine
Published: 2022-03-24 (Crawled : 15:30) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
vaccine
About 35% of People Who Received Placebo in Vaccine Trials Report Side Effects and More COVID-19 ...
Published: 2022-01-26 (Crawled : 15:30) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.05%
H: 1.0%
C: 0.5%
covid-19 als trials trial covid report vaccine
7MM COVID-19 Vaccines Market Outlook 2021-2026 incl. an Excel Model w/ Patient-based Sales Forecasts
Published: 2022-01-13 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 sales covid cel vaccine
Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose
Published: 2022-01-05 (Crawled : 15:30) - ir.zosanopharma.com
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 25.46%
H: 8.86%
C: -19.68%
system microneedle system injection vaccine influenza
Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (CORAL-BOOST) Evaluating a T Cell-Enhanced Self-Amplifying mRNA (samRNA) Vaccine Against COVID-19
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
GRTS | $0.7437 -0.2% -0.08% 2M
|
Health Technology
|
| O: -1.56%
H: 0.83%
C: -41.5%
covid-19 covid cel phase 1 positive results vaccine t-cell
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS
Published: 2021-12-30 (Crawled : 15:30) - globenewswire.com
OCGN | News A | $1.32 -8.33% -9.51% 7.7M
|
Health Technology
|
| O: -4.79%
H: 21.34%
C: 15.83%
bbv152 covid-19 xin covid positive children biotech vaccine iot
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India
Published: 2021-12-28 (Crawled : 15:30) - biospace.com/
NVAX | $3.89 0.26% 2.1M
|
Health Technology
|
| O: -2.94%
H: 14.91%
C: 1.75%
covid-19 covid authorization india vaccine merge emergency use authorization
New Study Finds Vaccine Dose Timing Reduces Risk of Long-COVID in Unvaccinated Patients
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
risk covid vaccine
Coronavirus (COVID-19) Update: FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters
Published: 2021-11-30 (Crawled : 15:30) - fda.gov
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
fda covid potential vaccine
NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological Research
Published: 2021-11-26 (Crawled : 15:30) - globenewswire.com
NRXP 1 d | $3.02 -27.75% -38.18% 760K
|
Manufacturing
|
| O: 2.44%
H: 0.0%
C: 0.0%
brilife covid israel vaccine research
Global Animal Vaccines Markets, 2021-2028: Breakdown by Poultry, Aqua, Ruminants, Companion, Canine, Feline, Swine
Published: 2021-11-15 (Crawled : 15:30) - prnewswire.com
PAHC | $13.04 1.32% 1.45% 79K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
NEOG P | $11.93 -1.73% -1.68% 2.9M
|
Health Technology
|
| O: 0.02%
H: 0.5%
C: -0.45%
vaccine
Health Canada Authorizes Booster Dose of Moderna’s COVID-19 Vaccine in Individuals 18 Years of Age and Older
Published: 2021-11-15 (Crawled : 15:30) - biospace.com/
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
covid vaccine order
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.